This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Z.-W. Articles by Holly, J. Search for Related Content PubMed PubMed Citation Articles by Zhang, Z.-W. Articles by Holly, J.

Prognostic Value of TP53 Codon 72 Polymorphism in Advanced Gastric Adenocarcinoma

¹Division of Surgery and² Department of Histopathology, Bristol Royal Infirmary, University of Bristol;³ Department of Histopathology, St. Bartholomew’s and the Royal London School of Medicine and Dentistry, London; and⁴ Faculty of Medicine, University of Glasgow, Glasgow, United Kingdom

Purpose: A common polymorphism of the tumor suppressor gene TP53 at codon 72 has been associated with human cancer susceptibility. The prognostic role of the polymorphism was assessed in 102 patients with advanced gastric adenocarcinoma.

Experimental Design: We followed up 102 consecutive Caucasian patients with advanced gastric adenocarcinoma for >5 years and determined the status of the TP53 codon 72 polymorphism in DNA samples extracted from archived gastric tissues.

Results: The frequency of the arginine homozygous allele was positively correlated to patient age at baseline (P = 0.002). However, the age-related increase in the percentage of codon 72 arginine p53 was not correlated to the prognosis for gastric cancer patients. Multivariable analysis in patients who had surgery showed that baseline age may be inversely associated with patient survival (odds ratio, 1.1; 95% confidence interval, 1.0–1.2; P = 0.02). Furthermore, alcohol consumption may be associated with reduced survival (P = 0.06).

Conclusions: These findings indicate that codon 72 arginine p53 may not be associated with a prolonged survival in patients with advanced gastric adenocarcinoma, but further study is needed to assess whether this polymorphism is associated with a late onset or slow progress of early gastric adenocarcinoma.

This article has been cited by other articles:

				S.-P. Huang, C.-Y. Huang, J.-S. Wang, C.-C. Liu, Y.-S. Pu, H.-J. Yu, C.-C. Yu, T. T. Wu, C.-H. Huang, W.-J. Wu, et al. Prognostic Significance of p53 and X-ray Repair Cross-complementing Group 1 Polymorphisms on Prostate-Specific Antigen Recurrence in Prostate Cancer Post Radical Prostatectomy Clin. Cancer Res., November 15, 2007; 13(22): 6632 - 6638. [Abstract] [Full Text] [PDF]

				D. Lattuada, P. Vigano, E. Somigliana, A. Abbiati, M. Candiani, and A.M. Di Blasio Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis Mol. Hum. Reprod., September 1, 2004; 10(9): 651 - 654. [Abstract] [Full Text] [PDF]